APAC Insulin Syringes Market Companies: Trends, and Market Insights

The insulin syringes market in the Asia-Pacific (APAC) region is expected to experience robust growth, with its market size projected to reach US$ 848.6 million by 2034. This growth is driven by increasing diabetes prevalence and technological advancements in syringe manufacturing. In 2024, the market is estimated at US$ 462.8 million, growing to US$ 491 million in 2025, reflecting a 6.1% CAGR from 2025 to 2034.

Table of Contents

APAC Insulin Syringes Market Overview

The APAC insulin syringes market is witnessing a steady rise due to the growing number of diabetes patients and increasing adoption of insulin delivery devices. The market is diverse in terms of syringe size, needle gauge, and length, with the 1.0 mL syringe holding the largest market share in 2024. The 0.3 mL syringe segment is expected to see the fastest growth rate during the forecast period. Similarly, the 31G-33G needle gauge category is the largest segment, with the >33G category anticipated to expand at the fastest pace in the coming years. The 6-8 mm needle length holds a significant portion of the market in 2024, with growing demand for more specialized and user-friendly devices.

Market Dynamics

CAGR: 6.1% (2025-2034)
2024 Market Size: US$ 462.8 million
2034 Projected Market Size: US$ 848.6 million

Key Syringe Segments in the Market

Syringe Size: The 1.0 mL syringe segment dominated the market in 2024, but the 0.3 mL syringe is expected to see the highest growth rate.
Needle Gauge: The 31G-33G segment was the largest in 2024, while the >33G category is expected to grow the fastest.
Needle Length: The 6-8 mm segment accounted for the largest share in 2024.

Top Companies in the APAC Insulin Syringes Market

Becton and Dickinson (BD)
- About: Becton Dickinson is a global leader in medical devices, offering advanced solutions for insulin delivery.
- Products: Insulin syringes, pen needles, and safety syringes.
- Market Cap: $80.91 Billion.
  Becton and Dickinson is renowned for its high-quality medical devices, including insulin syringes. The company leads the market with innovative products focused on safety and comfort.
Terumo Corporation
- About: Terumo is a Japanese multinational corporation known for providing medical devices and blood management products.
- Products: Insulin syringes, pen needles, infusion sets, and blood collection tubes.
- Market Cap: $37.45 Billion.
  Terumo is at the forefront of insulin syringe technology, offering a wide range of syringes tailored for diabetic patients. Its products focus on patient comfort and ease of use.
Nipro Corporation
- About: A global leader in medical devices, Nipro focuses on healthcare solutions with a strong presence in the diabetes management segment.
- Products: Insulin syringes, needles, blood glucose meters, and diabetes-related products.
- Market Cap: $6.62 Billion.
  Nipro is a key player in the APAC insulin syringes market, offering cost-effective and innovative solutions for insulin delivery.

HMD Healthcare Ltd
- About: HMD Healthcare is an Indian manufacturer specializing in a variety of medical products, including insulin syringes.
- Products: Insulin syringes, infusion sets, and pen needles.
- Market Cap: Not publicly listed.
  HMD Healthcare is known for producing reliable insulin syringes and needle devices used widely across healthcare facilities in India and other APAC regions.
Cardinal Health Inc.
- About: Cardinal Health is an American healthcare services and products company that provides a broad range of medical solutions.
- Products: Insulin syringes, needles, infusion pumps, and other medical devices.
- Market Cap: $19.61 Billion.
  Cardinal Health is recognized for its comprehensive portfolio of insulin delivery solutions, making it a significant player in the APAC market.
Roche Diagnostics (Accu-Chek)
- About: Roche Diagnostics, under the Accu-Chek brand, is a leading provider of diabetes management solutions.
- Products: Insulin syringes, glucose meters, and continuous glucose monitoring systems.
- Market Cap: $238.96 Billion.
  Roche Diagnostics continues to innovate in the insulin delivery space, focusing on precision and ease of use for diabetic patients.
Abbott Laboratories (Freestyle)
- About: Abbott Laboratories is a major player in healthcare, offering a wide array of medical devices and diagnostic solutions.
- Products: Insulin syringes, blood glucose monitoring systems, and diabetes care solutions.
- Market Cap: $242.81 Billion.
  Abbott Laboratories is at the cutting edge of diabetes management technologies, making insulin delivery more efficient and accessible.
Medtronic Plc
- About: Medtronic is a leading global medical technology company that focuses on innovative healthcare solutions.
- Products: Insulin syringes, infusion pumps, and insulin delivery systems.
- Market Cap: $743.94 Billion.
  Medtronic offers a wide range of products, including insulin syringes, with a focus on enhancing patient outcomes through advanced technology.
Dr. Morepen (Morepen Laboratories Ltd.)
- About: Dr. Morepen is a prominent pharmaceutical company that manufactures a variety of healthcare products, including insulin syringes.
- Products: Insulin syringes, glucose meters, and diabetes care products.
- Market Cap: $1.05 Billion.
  Dr. Morepen’s cost-effective insulin syringes are widely used across the APAC region, with a focus on quality and affordability.
Hindustan Syringes & Medical Devices Ltd. (HMD)
- About: HMD is a leading manufacturer of medical syringes and devices in India.
- Products: Insulin syringes, safety syringes, and prefilled syringes.
- Market Cap: Not publicly listed.
  HMD is renowned for producing high-quality, reliable insulin syringes, contributing significantly to the APAC market.
Poly Medicure Ltd.
- About: Poly Medicure Ltd. is a global healthcare company that manufactures a wide range of medical devices.
- Products: Insulin syringes, infusion sets, and blood collection products.
- Market Cap: $1.44 Billion.
  Poly Medicure’s innovative syringe solutions are widely recognized for their safety and precision in insulin delivery.
Ypsomed India Pvt. Ltd.
- About: Ypsomed is a Swiss-based healthcare company with a significant presence in the APAC market.
- Products: Insulin syringes, pens, and injection systems.
- Market Cap: $3.14 Billion.
  Ypsomed India focuses on providing high-quality insulin syringes designed for patient convenience and safety.
ARKRAY Healthcare Pvt. Ltd.
- About: ARKRAY is a leading company in diagnostics and healthcare solutions.
- Products: Insulin syringes, diabetes care devices, and monitoring systems.
- Market Cap: $5.12 Billion.
  ARKRAY specializes in high-quality syringes and devices to assist patients with effective diabetes management.

Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com

Frequently Asked Questions (FAQs)

1. What is the projected market size for the APAC insulin syringes market by 2034?
The APAC insulin syringes market is expected to reach US$ 848.6 million by 2034.

2. Which syringe size dominates the APAC insulin syringes market?
The 1.0 mL syringe segment held the largest market share in 2024.

3. What is the expected CAGR for the APAC insulin syringes market from 2025 to 2034?
The market is expected to grow at a CAGR of 6.1% during the forecast period.

4. Which needle gauge segment is expected to grow the fastest in the APAC market?
The >33G needle gauge segment is anticipated to experience the fastest growth.

5. What are the key players in the APAC insulin syringes market?
Key players include Becton and Dickinson, Terumo Corporation, Nipro Corporation, Cardinal Health Inc., Roche Diagnostics, Medtronic Plc, and Hindustan Syringes & Medical Devices Ltd., among others.

Source : https://www.towardshealthcare.com/insights/apac-insulin-syringes-market-sizing

Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5916